Partnerships | Isomorphic Labs
The same Isomorphic Labs partnerships page describes a strategic research collaboration with Eli Lilly and Company to discover small-molecule therapeutics against undisclosed targets, combining Isomorphic's AI-first drug design approach with Lilly's expertise. The page frames it as reflecting "a shared commitment to advancing drug design through cutting-edge science," but gives no specific announcement date, program count, or additional quotes for this partnership.
Google supplies AI to pharma through several distinct lines — Gemini/Vertex AI as an enterprise platform, and AlphaFold-based drug design licensed commercially through Isomorphic Labs.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Google on its own site — read the original case study on isomorphiclabs.com ↗
Related use cases
- 01Built an AI-native operating system for drug discovery on Google Cloud, using deep learning to speed development and success rate of new treatments.
- 02XtalPi: Accelerating drug discovery and development to offer more timely and affordable medical treatments
- 03AI-based computational disease models on Google Cloud to help pharma shorten clinical trials and cut drug-development costs.
- 04Oncology biotech uses Google Cloud to scale molecular dynamics simulations, cutting simulation time from weeks to overnight and false positives by 50%.
- 05Cradle: Revolutionizing Protein Engineering with a secure AI platform built on Google Cloud
- 06AI-driven drug discovery company; moved to GKE for flexible, scalable protein-structure processing (millions of structures).